BCI
IMGN

Brinker Capital Investments’s Immunogen Inc IMGN Stock Holding History

Brinker Capital Investments’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-13,571
Closed -$215K – 1773
2023
Q3 		$215K Buy
13,571
+2,802
+26% +$46.6K ﹤0.01% 1523
2023
Q2 		$203K Buy
+10,769
New +$127K ﹤0.01% 1554
2019
Q4 		– Sell
-131
Closed – – 885
2019
Q3 		$0 Buy
+131
New +$348 ﹤0.01% 980

Other funds holding IMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Brinker Capital Investments's IMGN Position: Q4 2023 in Review

Brinker Capital Investments sold out of Immunogen Inc (IMGN) in Q4 2023, closing a stake of 13,571 shares — an estimated $215K sold.

Brinker Capital Investments first reported a position in IMGN in Q3 2019 and held it in 3 quarters. The position peaked at $215K in Q3 2023. 327 funds tracked by Wall St. Rank hold IMGN as of Q4 2023.

  • Brinker Capital Investments reported no remaining Immunogen Inc position as of Q4 2023 after selling out during the quarter.
  • Brinker Capital Investments sold 13,571 Immunogen Inc shares in Q4 2023, an estimated $215K.
  • Brinker Capital Investments first reported a position in Immunogen Inc in Q3 2019 and held it in 3 quarters.
  • Brinker Capital Investments's Immunogen Inc position peaked at $215K in Q3 2023.
  • 327 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2023.

Based on Brinker Capital Investments's 13F filing for Q4 2023, filed 31 Jul 2025.